Real-time enrollment status for this metastatic pancreatic ductal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 5:14 PM UTC
| NCT Number | NCT07214298 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Pancreatic Ductal Adenocarcinoma |
| Phase | PHASE1 |
| Target Enrollment | 35 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Roswell Park Cancer Institute |
| Last Updated on CT.gov | June 8, 2026 (Jun 8, 2026) |
As of July 18, 2026: Clinical trial NCT07214298 is currently recruiting participants. This phase1 study for metastatic pancreatic ductal adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Roswell Park Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07214298 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07214298 was last updated Jun 8, 2026 (June 8, 2026). HelloStudys verifies this status automatically.